CME Group said it entered into an Underwriting Agreement on March 3, 2025 and issued and sold an aggregate principal amount of $750,000,000 of its 4.400% Notes due 2030 in an underwritten public offering.

1. 01

   CME Group said it entered into an Underwriting Agreement on March 3, 2025 and issued and sold an aggregate principal amount of $750,000,000 of its 4.400% Notes due 2030 in an underwritten public offering.

2. 02

   The company disclosed that it entered into the Underwriting Agreement on March 3, 2025, with Barclays Capital Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC acting as representatives of the underwriters.

3. 03

   CME Group said the Underwriting Agreement includes customary representations, warranties and covenants from the company, and that the company and the underwriters each provide customary indemnification for certain liabilities, along with related customary contribution provisions.

4. 04

   The company said it filed the Underwriting Agreement dated March 3, 2025 as Exhibit 1.1, and that its description of the agreement is qualified in its entirety by the full text of the agreement.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.